Shorter timelines, evolving strategies: Four key trends in regulatory approvals of new medicines
Clarivate
AUGUST 2, 2022
The following blog post summarizes key findings from the latest CIRS R&D Briefing, New drug approvals in six major authorities 2012-2021. The resulting analyses, published annually since 2012, give unique insights into regulatory processes and practices, identify where improvements can be made and inform company and agency strategies.
Let's personalize your content